drugset / Trial / NCT00522275

Determine Safety and Efficacy of Long-term Oral Lacosamide in Patients With Partial Seizures

NCT00522275

Phase 3 Completed 308 enrolled UCB BIOSCIENCES, Inc.
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this trial is to determine whether lacosamide is safe and effective for long-term use in patients with partial-seizures from epilepsy

Timeline

Start
2004-10
Primary completion
2009-10
Completion
2009-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Lacosamide Other / unclassified 800 mg Oral

Indications